Navigation Links
Hormone Combo May Provide Reversible Male Birth Control Tool
Date:3/28/2008

Testosterone coupled with progestin effectively suppressed sperm production

FRIDAY, March 28 (HealthDay News) -- A combination of testosterone and progestin suppresses sperm production faster and more completely than testosterone alone, according to an analysis by an international team of researchers.

The scientists said that hormonal contraception may become a safe, effective and reversible form of male birth control.

"It is possible to suppress sperm output to concentrations that are comparable with reliable contraception in most, but not all men. The rate of suppression is comparable to that achieved after a vasectomy," lead author Peter Y. Liu, an associate professor at the University of Sydney, Australia, said in a prepared statement.

Testosterone and other male hormones create "negative feedback" in the male reproductive system, which suppresses sperm production.

In this study, Liu and colleagues analyzed 30 male hormonal contraceptive studies that included a total of 1,756 men, aged 18 to 51. In these studies, conducted from 1990 to 2006, the men received different preparations of testosterone, with or without various preparations of the hormone progestin.

Testosterone is the primary male sex hormone. Progestin (a synthetic progesterone), which is used in combination with estrogen for female contraception, is not ordinarily produced by men.

The analysis revealed that the combination of testosterone and progestin was more effective at suppressing sperm production that testosterone alone.

"Progestin co-administered with testosterone increased both the rate and extent of suppression. It also may make long-term hormonal contraception safer by reducing the dose of testosterone needed for maintenance contraception," Liu said.

The analysis also showed that treatment suppressed sperm output more quickly in white males but not as completely as in non-whites. Younger men with lower testosterone levels also had faster sperm production suppression.

The review authors also found that it's difficult to predict which men will respond best to this combination hormonal contraception.

"Considerable progress has been made toward finding an effective combination of these two hormones. However, the current analysis didn't take into account the different types of progestins, so more research will need to be done to find the optimum therapy," Liu said.

The study was published in the Journal of Clinical Endocrinology & Metabolism.

More information

The American Academy of Family Physicians has more about birth control.



-- Robert Preidt



SOURCE: Endocrine Society, news release, March 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Alert to Women: What Your Doctor Prescribed for Hormone Replacement May Be Killing You and Your Rights Are About to Be Taken Away
2. Thyroid Hormone Could One Day Treat Osteoporosis
3. Low levels of PYY hormone a very early indicator of type 2 diabetes
4. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
5. Cancer risk slightly higher for women in discontinued hormone treatment trial
6. Health risks after cessation of postmenopausal hormone therapy
7. Heart Hormones Beat Back Cancers in Mice
8. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
9. Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis
10. Hormone therapy increases frequency of abnormal mammograms, breast biopsies
11. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: